Clinical Trial Update: Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan/cisplatin with or without simvastatin in chemo-naive extensive-disease small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Small Cell Lung Carcinoma | Phase 2 | Status: UNKNOWN